Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

57%

4 of 7 completed trials have results

Key Signals

1 recruiting4 with results

Enrollment Performance

Analytics

N/A
8(88.9%)
Phase 2
1(11.1%)
9Total
N/A(8)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials
NCT03919695Not ApplicableCompleted

Development of an Intervention to Reduce Heavy Drinking and Improve HIV Care Engagement Among Fisherfolk in Uganda

Role: collaborator

NCT06949774Not ApplicableRecruiting

INcentives and ReMINDers to Improve Long-term Medication Adherence (INMIND)

Role: collaborator

NCT05131165Not ApplicableCompleted

INcentives and ReMINDers to Improve Long-term Medication Adherence

Role: collaborator

NCT05378607Not ApplicableActive Not Recruiting

Goals for Adherence with Low-cost Incentives

Role: collaborator

NCT03892915Phase 2Completed

Maternal Depression Treatment in HIV

Role: collaborator

NCT05084716Not ApplicableCompleted

Pre-Exposure Prophylaxis (PrEP) Provision for Ugandan Fisherfolk

Role: collaborator

NCT06058845Not ApplicableCompleted

Efficacy of Tamarindus Indica Fruit Juice in Optimizing Cardiometabolic Health of Patients Living With HIV

Role: collaborator

NCT03494777Not ApplicableCompleted

Behavioral Economics Incentives to Support HIV Treatment Adherence in Sub-Saharan Africa

Role: collaborator

NCT02503072Not ApplicableCompleted

Rewarding Adherence Program - an Intervention Using Small Prizes Allocated by a Prize Drawing to Increase ARV Adherence

Role: collaborator

All 9 trials loaded